MedicineOncologyPreventive MedicineCancer ScreeningEpidemiologySurvival AnalysisCancer PolicyCancer Survival AnalysisCervical CancerDisease ControlPopulation ScreeningRisk ReductionCancer Registry EvaluationCancer Screening EpidemiologyCervical Cancer ScreeningCervical Carcinoma ScreeningEarly ScreeningPreventive Screening EducationScreening Program Implementation
Cancer has become a leading cause of death and aroused the cancer scare. Breast and cervical cancer are two main health threats for women. In order to reduce mortality through early detection and early treatment, cancer screening has been widely recommended and applied for breast and cervical cancer detection and prevention. However, the benefit of cancer screening has been a controversial issue for the recent decades. The Chinese government has launched a free screening program on breast and cervical cancer for women since 2009. There is lack of strong data and sufficient information, however, to examine the effect of breast and cervical cancer screening. A Difference-in-Difference model estimated by Cox proportional hazard estimation was applied to evaluate the effects of breast and cervical cancer screening using data from Nown County Cancer Registry between the year 2009 and 2013. Based on the case study in a county of central China, this study found that the screening program reduced the risk of death, but found the lion's share for the benefit has been mainly due to the cervical cancer screening rather breast cancer screening, which may be related to the difference between early detection screening and preventive screening. Our results suggest sufficient funding and better education of related cancer knowledge will be meaningful measures for the prevention and treatment of breast and cervical cancer.
39
Cancer statistics in China, 2015
Wanqing Chen, Rongshou Zheng, Peter D. Baade et al. · CA A Cancer Journal for Clinicians · 2016 · 18K citations · Full text
The Papanicolaou Test for Cervical Cancer Detection
Leopold G. Koss · JAMA · 1989 · 658 citations
Medicine, Gynecology, Pathology +17